CGS-19755

Author(s):  
L. Charles Murrin
Keyword(s):  
1988 ◽  
Vol 154 (1) ◽  
pp. 89-93 ◽  
Author(s):  
J. Lehmann ◽  
A.G. Chapman ◽  
B.S. Meldrum ◽  
A. Hutchison ◽  
C. Tsai ◽  
...  

1990 ◽  
Vol 10 (3) ◽  
pp. 343-351 ◽  
Author(s):  
Jeanette H. Swan ◽  
Brian S. Meldrum

We have administered antagonists acting competitively or noncompetitively at the N-methyl-D-aspartate receptor after a short period of incomplete ischaemia and evaluated selective neuronal loss in the CA1 region of the rat hippocampus. The competitive antagonists D-(–)-2-amino-7-phosphonoheptanoate (2APH); 100 or 330 mg/kg; 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonate (CPP); 3.3 or 10 mg/kg; and CGS 19755 ( cis-4-phosphonomethyl-2-piperidine carboxylate) 3.3 or 10 mg/kg; and the noncompetitive antagonists MK801 {(+)5-methyl-10, 11-dihydro-5H-dibenzo[ a,d]cyclohepten-5,10-imine maleate}, 0.3, 1, or 3 mg/kg, and dextrorphan, 2, 6, 18, or 54 mg/kg, were administered intraperitoneally 15 min and 5 h after a 10-min incomplete ischaemia period; additionally MK801 (1 or 3 mg/kg) and CGS 19755 (10 or 30 mg/kg) were administered 5 and 10 h postischaemia. Seven days after ischaemia, the brains were fixed by perfusion. CA1 pyramidal cell counts were performed on Nissl-stained sections using an ocular grid piece. Ventilated (no ischaemia) control animals had a mean of 406 ± 13 CA1 neurones/3 grid lengths. Ischaemia reduced this mean to 157 ± 23. A significant protective effect against this cell loss was seen after two injections (at 15 min and 5 h postischaemia) of 2APH, CPP (10 mg/kg), CGS 19755 (10 mg/kg), MK801 (1 mg/kg), and dextrorphan (54 mg/kg). Delayed injection (5 and 10 h postischaemia) of CGS 19755 (10 and 30 mg/kg) and MK801 (1 and 3 mg/kg) did not provide any protection against pyramidal cell loss.


Neuroscience ◽  
1993 ◽  
Vol 56 (4) ◽  
pp. 915-920 ◽  
Author(s):  
A. Shuaib ◽  
S. Ijaz ◽  
R. Mazagri ◽  
A. Senthilsevlvan
Keyword(s):  

1997 ◽  
Vol 16 (2) ◽  
pp. 175-181 ◽  
Author(s):  
Kirk R. Huber ◽  
Pritam S. Sahota ◽  
John Kapeghian ◽  
Helen Han Hsu ◽  
Kenjie Amemiya ◽  
...  

Several N-methyl-D-aspartate (N M D A) receptor antagonists are being developed to reduce overstimulation of N M D A receptors by excessive glutamate, released as a consequence of acute cerebral hypoxial ischemia after stroke or head trauma. N M D A receptor antagonists, including Selfotel (C G S 19755), have been demonstrated to cause neuronal vacuolation and neuronal necrosis in the retrosplenial and / or posterior cingulate cerebral cortices of rats; however, little in formation is available on their effects on the cerebral cortices of primates. Cynomolgus monkeys were treated with single parenteral doses of N M D A antagonists (Selfotel or M K-801). Monkeys were administered intravenous doses of Selfotel at 2 or 20 mg/kg and were necropsied 4, 24, or 72 h postdose. Additional monkeys, administered M K-801 subcutaneously at 0.25 mg/kg, were necropsied 4 or 72 h postdose. Overt, centrally mediated clinical signs occurred in both Selfote l- and M K-801–treated monkeys (e.g., at axia, hypoactivity, salivation, convulsions, disorientation, dyspnea, apnea, recumbency, and cyanosis). Brains were perfusion-fixed in situ with 1% paraformaldehyde and 1.5% glutaraldehyde in pyrophosphate buffer. Brain sections from the animals necropsied 4 and 24 h postdose we reembedded in plastics (Durcupan) and paraffin, cut at 1 or 2 μm thickness, and stained with Richardson's stain. Brains from the animals necropsie d 72 h postdose were embedded in paraffin, cut at 4 μm, and stained with hematoxylin and eosin. Microscopic examination of posterior cingulate and/or retrosplenial cerebral cortices from monkey streated with Selfotel or M K-801 did not reveal any neuronal vacuolation or necrosis.


Sign in / Sign up

Export Citation Format

Share Document